Adalimumab-Bwwd
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Adalimumab-Bwwd is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $7 million on Adalimumab-Bwwd across 6,000 claims for 1,317 beneficiaries.
Adalimumab-Bwwd is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $623.49 to $1259.15 per ML — the most expensive product costs about 2.0× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$623.49 – $1259.15
per ML
7d Activity
avg +0.1% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Organon LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Tumor Necrosis Factor Blocker class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing ADALIMUMAB-BWWD
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
HADLIMA(CF) PUSHTOUCH 40 MG/0.4 ML | $1259.1544 per ML | +0.03% |
HADLIMA(CF) 40 MG/0.4 ML SYRINGE | $1258.3781 per ML | +0.30% |
HADLIMA PUSHTOUCH 40 MG/0.8 ML | $623.4931 per ML | +0.12% |
Frequently Asked Questions
What is Adalimumab-Bwwd used to treat?
Adalimumab-Bwwd is used to treat juvenile arthritis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, crohn disease and hidradenitis suppurativa, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Adalimumab-Bwwd?
In 2024, Medicare Part D spent $7 million on Adalimumab-Bwwd across 6,000 claims for 1,317 beneficiaries.
How many Adalimumab-Bwwd products are on the market?
The Adalimumab-Bwwd drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Adalimumab-Bwwd?
NADAC reference prices for Adalimumab-Bwwd range from $623.4931 to $1259.1544 per ML — the most expensive product costs about 2.0× the cheapest.
Which manufacturers make Adalimumab-Bwwd?
1 manufacturer lists Adalimumab-Bwwd in NADAC. Ranked by number of NDCs, the largest are Organon LLC (3).
How has the price of Adalimumab-Bwwd changed recently?
Over the past 7 days, 3 Adalimumab-Bwwd NDCs rose and 0 fell, with a market-wide average change of +0.1%.